CD274 and Merkel cell skin cancer: Although immune checkpoint inhibitors (ICIs) targeting programmed cell death protein one and its ligand (PD1/PD-L1) have become the standard of care for advanced MCC, resistance develops in the majority of treated patients [8,9,10,11].